Research teams that develop the most effective clinical protocol for the use of CT scans in fighting COVID-19 will be awarded prizes from the USD 1.8m purse.
The new COVID-19 CT Scan Collaborative includes Mount Sinai Hospital, the Open-QIC COVID Registry and the endcoronavirus.org network.
XPRIZE is in designing and operating incentive competitions to solve humanity's grand challenges, and it recently announced a global XPRIZE Pandemic Alliance, which launched two major international competitions to address the COVID-19 pandemic: the XPRIZE NextGen Mask Challenge and XPRIZE Rapid COVID Testing.
The COVID-19 CT Scan Collaborative will operate the prize, and the XPRIZE Pandemic Alliance will help develop best practices and convene teams for the competition.
CT scans with high detection capabilities have the potential to increase testing access, disease monitoring and identification of early and asymptomatic cases.
As new radiology protocols typically take years to develop, this unprecedented, real-time collaboration will enable radiologists worldwide to view anonymized CT scans to improve their results.
The goal of the COVID-19 CT Scan Collaborative is to exponentially advance the development of CT scan clinical protocols for management of COVID-19 infections and increase the availability, ease and accuracy of diagnoses.
XPRIZE, a 501(c) (3) nonprofit, is a leader in designing and implementing innovative competition models to solve the world's grandest challenges.
The XPRIZE Pandemic Alliance is a global coalition that combines the power of collaboration, competition, innovation and radical thinking to accelerate solutions that can be applied to COVID-19 and future pandemics.
The New England Complex Systems Institute (NECSI) is an independent academic research and educational institution with students, postdoctoral fellows and faculty. In addition to the in-house research team, NECSI has co-faculty, students and affiliates from MIT, Harvard, Brandeis and other leading institutions.
EndCoronavirus is an international volunteer coalition of over 15,000 scientists and experts who develop and promote community-based solutions for policy makers, businesses and individuals. It was founded by The New England Complex Systems Institute in February 2020.
AstraZeneca's Fasenra misses primary endpoint in Phase III COPD trial
Hemogenyx reports positive safety and early efficacy data from third patient in CAR-T trial
Sanofi reports positive phase 2a results for brivekimig in hidradenitis suppurativa
GSK commits USD30bn to US R&D and manufacturing expansion
Neurocrine Biosciences announces presentation of Osavampator Phase 2 data at Psych Congress 2025
Ascletis presents ASC30 study results at EASD Annual Meeting
Three WuXi Biologics manufacturing facilities receive GMP certification from Turkish regulator
VarmX secures strategic collaboration and option agreement with CSL for novel coagulation therapy
Avidity Biosciences closes USD690m public offering of common stock
Akeso's ligufalimab (CD47 mAb) granted FDA Orphan Drug Designation for AML
Forte Biosciences highlights positive FB102 data in celiac disease at Tampere Symposium
SureSpace Launches in Dubai to Tackle Doomscrolling and Redefine Social Networking
Kodiak reports positive APEX data for KSI-101 in macular edema secondary to inflammation
Biophytis secures Brazilian funding and partnerships for obesity Phase 2 trial